A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) ...

According to ImmunityBio, thousands of vials of rBCG are now available and ... an interleukin-15 receptor agonist, indicated with BCG for adult patients with BCG-unresponsive non-muscle invasive ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...

IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...

The new method, published in npj Vaccines, analyzes the vaccine vial label and its adhesive and therefore allows the vaccine vials to be retained in the supply chain. Furthermore, the study has ...

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital ...

[JONAH ONYANGO/STANDARD.] A nationwide shortage of Bacillus Calmette-Guerin (BCG) vaccines in the country leaves Kenyan newborns vulnerable to Tuberculosis (TB), a disease with a high prevalence ...

Jane Akinyi (right) holding her baby while a medic adminster a Bacillus Calmette–Guérin vaccine(BCG) vaccine at Forest Dispensary in Nakuru on January 28,2019.Most of the hospitals in the ...

BCG is one of the most widely used vaccines worldwide ... Instill intravesically only after dilution. Total time from vial puncture to the completion of the intravesical instillation should ...